These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10390389)

  • 21. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD; Moore A; Mersmann S; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR; Stallaert RA; Prins J; Greefhorst AP; Bosman HG; van Uffelen R; Schreurs AJ; van Helmond JL; Janssen PG
    J Asthma; 1998; 35(4):337-45. PubMed ID: 9669827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
    Bateman ED; Bleecker ER; Lötvall J; Woodcock A; Forth R; Medley H; Davis AM; Jacques L; Haumann B; Busse WW
    Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.
    Vaessen-Verberne AA; van den Berg NJ; van Nierop JC; Brackel HJ; Gerrits GP; Hop WC; Duiverman EJ;
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1221-7. PubMed ID: 20622031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing.
    Teper AM; Colom AJ; Kofman CD; Maffey AF; Vidaurreta SM; Bergadá I
    Pediatr Pulmonol; 2004 Feb; 37(2):111-5. PubMed ID: 14730655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
    Bisgaard H; Allen DB; Milanowski J; Kalev I; Willits L; Davies P
    Pediatrics; 2004 Feb; 113(2):e87-94. PubMed ID: 14754977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
    de Blic J; Ogorodova L; Klink R; Sidorenko I; Valiulis A; Hofman J; Bennedbaek O; Anderton S; Attali V; Desfougeres JL; Poterre M
    Pediatr Allergy Immunol; 2009 Dec; 20(8):763-71. PubMed ID: 19239660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH; Wong HH; Liu JT; Fahy JV
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial.
    Schokker S; Kooi EM; de Vries TW; Brand PL; Mulder PG; Duiverman EJ; van der Molen T
    Pulm Pharmacol Ther; 2008; 21(1):88-97. PubMed ID: 17350868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
    Visser MJ; Postma DS; Arends LR; de Vries TW; Duiverman EJ; Brand PL
    Am J Respir Crit Care Med; 2001 Dec; 164(11):2073-7. PubMed ID: 11739137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.